TLR2 and gastric cancer: Analysis of the expression of TLR-2, -3, -4, and -9 receptors on CD3-CD56+ and CD3+CD56+ cells in different disease stages revealed clear differences in expression levels depending on disease stage, which may indicate enhanced immune activation in more advanced stages of GC.